Host Response to Infection and Treatment in Filarial Diseases

NCT00001230 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

NIH

Sponsor class

Conditions

Filariasis
Helminthiasis
Parasitic Infection
Mansonelliasis
Onchocerciasis

Interventions

DRUG: Diethylcarbamazine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)